Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.56 USD | -0.04% | -1.87% | -11.88% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.88% | 230M | |
+30.04% | 457B | |
+30.94% | 276B | |
+3.99% | 137B | |
+29.39% | 93.68B | |
+4.82% | 90.6B | |
+60.72% | 59.25B | |
+11.88% | 45.65B | |
+24.63% | 37.59B | |
-1.72% | 35.62B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Roth MKM Adjusts Price Target on OptimizeRx to $20 From $31, Maintains Buy Rating